Trial of ibrutinib with bendamustine and rituximab in CLL: results and study design
How to avoid tumor lysis syndrome when treating CLL patients with venetoclax
Inotuzumab ozogamicin for the treatment of elderly acute lymphoblastic leukemia
Inherited and acquired genetic factors involved in the development of CLL
John Gribben et al.
Overview of a Phase Ib study of venetoclax and obinutuzumab in CLL